Antivenin (crotalidae) polyvalent Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Jul 4, 2022.
Antivenin (crotalidae) polyvalent is also known as: Anavip, Antivenin Polyvalent, CroFab
Antivenin (crotalidae) polyvalent Pregnancy Warnings
Animal studies have not been conducted. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Use is not recommended unless clearly needed.
US FDA pregnancy category: C
Comments:
-This product contains ethyl mercury from thimerosal.
-Limited data on high dose and acute exposures to methyl mercury associate it with neurological and renal toxicities.
-Developing fetuses and very young children are more susceptible to methyl mercury toxicity.
Antivenin (crotalidae) polyvalent Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
See also
References for pregnancy information
- "Product Information. CroFab (antivenin (Crotalidae) polyvalent)." Savage Laboratories
References for breastfeeding information
- "Product Information. CroFab (antivenin (Crotalidae) polyvalent)." Savage Laboratories
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.